GDG meetingDeclaration of Interests
GDG ApplicationNo interests to declare
First GDG meeting (10th July 2009)No change in declaration
Second GDG Meeting (04th September 2009)No change in declaration
Third GDG Meeting (14th October 2009)No change in declaration
Fourth GDG Meeting (27th November 2009)No change in declaration
Fifth GDG Meeting (13th January 2010)No change in declaration
Sixth GDG Meeting (26th February 2010)SA declared the following item of personal pecuniary interest:
  • Attended a study event (state of the heart) which was sponsored by Astra Zeneca; The event was unrelated to stable angina and any of the drugs associated with stable angina
Seventh GDG Meeting (26th March 2010)SA declared the following item of personal pecuniary interest:
  • Receipt of honoraria for participation in an Advisory Board for Astra Zeneca for a drug unrelated to stable angina.
Eighth GDG Meeting (14th May 2010)SA declared the following item of personal pecuniary interest:
  • Receipt of honorarium from GSK for presentation on a drug unrelated to the treatment of stable angina
  • Receipt of honoraria for participation in an Advisory Board for Bayer for a drug unrelated to stable angina.
Ninth GDG Meeting (18th June 2010)No change in declaration
Tenth GDG Meeting (23rd July 2010)No change in declaration
Eleventh GDG Meeting (08th September 2010)SA declared the following item of personal pecuniary interest:
  • Receipt of honoraria for participation in an Advisory Board on the development of an Integrated Care Pathway unrelated to Stable angina sponsored by Chiesi.
Twelfth GDG Meeting (22nd October 2010)SA declared the following item of personal pecuniary interest:
  • Presented at HRC meeting and was sponsored by Sanofi Aventis
Thirteenth GDG Meeting (4th March 2011)No change in declaration

From: Appendix J, Declarations of interests

Cover of Stable Angina
Stable Angina: Methods, Evidence & Guidance [Internet].
NICE Clinical Guidelines, No. 126.
National Clinical Guidelines Centre (UK).
Copyright © 2011, National Clinical Guidelines Centre.

Apart from any fair dealing for the purposes of research or private study, criticism or review, as permitted under the Copyright, Designs and Patents Act, 1988, no part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

The rights of the National Clinical Guidelines Centre to be identified as Author of this work have been asserted by them in accordance with the Copyright, Designs and Patents Act, 1988.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.